Innovating Works

H2020

Cerrada
HORIZON-EIC-2022-TRANSITIONOPEN-01
EIC Transition Open 2022
Expected Impact:At the end of the EIC Transition project, it should be ready for the next stage, which can be to apply for EIC Accelerator (if you are a SME, including start-ups or spin-offs), to seek other investors or sources of funding, to enter licensing or collaboration agreements with third parties, or other routes to market deployment. In case the project is not led by an SME or commercial partner, the formation and spin out of a new company can be included as part of the activities. It will be expected to describe the intended pathway and route to market in the proposal, and to specify milestones and KPIs during the implementation of your project to assess progress towards the market.
Sólo fondo perdido 100%
Europeo
Mostrando 41 al 60 de 328 resultados
EV FOx: Extracellular Vesicles Fiber Optic Surface Plasmon Resonance selection and analysis FOX BIOSYSTEMS NV tramitó un HORIZON EUROPE: HORIZON-EIC-2022-ACCELERATOR-01 The Extracellular vesicles (EV) field is growing due to increased interest in their roles in diagnostics and therapeutics. Current methods t...
2023-04-11 - 2025-06-30 | Financiado
ELVIS: ELEM Virtual Heart Populations for Supercomputers ELEM BIOTECH tramitó un HORIZON EUROPE: HORIZON-EIC-2022-ACCELERATOR-01 ELEM’s V.Heart is a supercomputer-based platform to perform massive in-silico clinical trials on populations of digital avatars generated th...
2023-04-11 - 2025-02-28 | Financiado
Releaf Paper - sustainable leaves-based paper: Releaf Paper - breakthrough technology for sustainable production of leaves-based fibre disrupting p... RELEAF PAPER FRANCE SAS tramitó un HORIZON EUROPE: HORIZON-EIC-2022-ACCELERATOR-01 Releaf Paper is the first and the only producer of cellulose from fallen leaves in the world with a patent for the technology based on a uni...
2023-04-10 - 2025-04-30 | Financiado
ReTreatPD: Revolutionary therapeutic treatment for stopping progression of Parkinson's disease HERANTIS PHARMA OYJ tramitó un HORIZON EUROPE: HORIZON-EIC-2022-ACCELERATOR-01 Parkinson's disease (PD) is a common neurodegenerative disorder, affecting over 10 million people worldwide, whereof 1.2 million in the EU....
2023-04-07 - 2025-04-30 | Financiado
Simulated Reality: SR - the next generation display technology that empowers users to naturally and intuitively work, p... DIMENCO HOLDING BV tramitó un HORIZON EUROPE: HORIZON-EIC-2022-ACCELERATOR-01 Dimenco builds Simulated Reality technology, a revolutionary new form of spatial computing that combines lenticular light-field display tech...
2023-04-07 - 2024-12-31 | Financiado
Cyanide Extraction Technology: Technology to detoxify oilseeds / fruit seeds that contain cyanogenic glycosides to upcycle and maki... KERN TEC GMBH tramitó un HORIZON EUROPE: HORIZON-EIC-2022-ACCELERATOR-01 Millions of tons of oil seeds / fruit seeds, especially their protein-rich presscakes currently go to waste as they contain a too high amoun...
2023-04-07 - 2025-02-28 | Financiado
regenera: A natural breast for cancer survivors: resorbable implant supporting tissue regeneration TENSIVE SRL tramitó un HORIZON EUROPE: HORIZON-EIC-2022-ACCELERATOR-01 Of the 3 million women undergoing breast cancer resection every year, only a few opt for breast reconstruction due to pain, concerns about f...
2023-04-07 - 2025-02-28 | Financiado
d3pm: Sonio: Deep-Learning for Detection and Diagnostic of Prenatal Malformations SONIO tramitó un HORIZON EUROPE: HORIZON-EIC-2022-ACCELERATOR-01 1 child out of 33 is born with a congenital malformation in developed countries, leading to mortality & disability which impact the children...
2023-04-06 - 2024-12-31 | Financiado
BIC ONE: Brain Interchange ONE SR—the implantable neuromodulation technology for stroke rehabilitation CORTEC GMBH tramitó un HORIZON EUROPE: HORIZON-EIC-2022-ACCELERATOR-01 Electrical brain stimulation has been successfully used since the 1990s to treat neurological illnesses, particularly movement disorders. M...
2023-04-06 - 2024-10-31 | Financiado
Endurance: In-Orbit Services to Satellites Operators INFINITE ORBITS tramitó un HORIZON EUROPE: HORIZON-EIC-2022-ACCELERATOR-01 Infinite Orbits is shaping the new market for space infrastructures by providing services to repair, maintain or protect Spacecraft In Orbit...
2023-04-06 - 2025-03-31 | Financiado
NeuroClues: the clinical must-have for Neurologist: NeuroClues: the clinical must-have for Neurologists: clinical validation, industrialization, and go-... P3 LAB tramitó un HORIZON EUROPE: HORIZON-EIC-2022-ACCELERATOR-01 P3Lab developed NeuroClues, a first-of-a-kind portable, fast and easy to use eye tracking medical device that brings clinically validated ey...
2023-04-06 - 2027-01-31 | Financiado
Maeve 01: Maeve 01 - an All-electric Commuter Aircraft MAEVE AEROSPACE B.V. tramitó un HORIZON EUROPE: HORIZON-EIC-2022-ACCELERATOR-01 There’s a pressing demand for green aviation in the EU: e.g. Denmark and Sweden aim at 100% fossil-free domestic flights by 2030, and Norway...
2023-04-06 - 2024-12-31 | Financiado
LVOCheck: Diagnosis of large vessel occlusion (LVO) in acute stroke for improving access to treatment ADVANCED BRAIN COMPANION DIAGNOSTICS SPAIN SL tramitó un HORIZON EUROPE: HORIZON-EIC-2022-ACCELERATOR-01 LVOCheck is a portable diagnostic solution providing fast identification of large vessel occlusion (LVO) in acute stroke, just by analysing...
2023-04-06 - 2025-04-30 | Financiado
Agri-Think Robot: A Disruptively New Approach to Weed Management Shaping the Future of Sustainable Agriculture ODD.BOT BV tramitó un HORIZON EUROPE: HORIZON-EIC-2022-ACCELERATOR-01 Odd.bot is a technology start-up in the Netherlands creating the first 100% environmentally friendly, autonomous weed management robot in th...
2023-04-06 - 2024-12-31 | Financiado
CURE-PDAC: Acceleration of the world’s first autotaxin inhibitor for the treatment of pancreatic cancer (PDAC) IONCTURA BV tramitó un HORIZON EUROPE: HORIZON-EIC-2022-ACCELERATOR-01 IOnctura is a clinical stage biopharmaceutical company dedicated to delivering innovative cancer treatments to patents with unmet medical ne...
2023-04-06 - 2025-03-31 | Financiado
Aeson®: The World’s Only Bioprosthetic Auto-regulated Artificial Heart: From Total Artificial Heart (TAH) to... CARMAT tramitó un HORIZON EUROPE: HORIZON-EIC-2022-ACCELERATOR-01 At Carmat we have designed and developed Aeson®, the world’s most advanced total artificial heart (TAH), aiming to fulfill an unmet medical...
2023-04-06 - 2024-09-30 | Financiado
EGNITE: Engineering Graphene for developing Neural Interfaces to revolutionize how we treat neurological dis... INBRAIN NEUROELECTRONICS tramitó un HORIZON EUROPE: HORIZON-EIC-2022-ACCELERATOR-01 Neurological disorders represent one of the greatest healthcare challenges for our society (1B affected people worldwide). 25-35% of these p...
2023-04-06 - 2025-04-30 | Financiado
FaradaIC: FaradaIC: Miniaturising Gas Sensors to enable new sensing possibilities in IoT devices FARADAIC SENSORS GMBH tramitó un HORIZON EUROPE: HORIZON-EIC-2022-ACCELERATOR-01 FaradaIC is bringing to the market the first miniaturised electrochemical O2 gas sensor to enable new sensing opportunities across different...
2023-04-06 - 2025-02-28 | Financiado
Next level cataract surgery: New era of guided lens implantation in cataract surgery AKKNATEK GMBH tramitó un HORIZON EUROPE: HORIZON-EIC-2022-ACCELERATOR-01 AkknaTek’s device-based solution is introducing a unique imaging technology to overcome the current hurdles of nowadays cataract surgery. It...
2023-04-06 - 2025-04-30 | Financiado
Dynamic Molding (DM): An innovative and versatile Additive Manufacturing Process: Dynamic Molding 3DEUS DYNAMICS SAS tramitó un HORIZON EUROPE: HORIZON-EIC-2022-ACCELERATOR-01 3D printing technology is marred by various challenges including but not limited to longer production time, restricted design, production wa...
2023-04-05 - 2025-04-30 | Financiado